How Immunotherapy Is Revolutionizing Lung Cancer Treatment
In general, there are two types of lung cancer: small cell and non-small cell. Non-small cell lung cancer (NSCLC) is the most common type, accounting for about 85% of lung cancers. When NSCLC is in its early stages, doctors will typically remove the tumors via surgery and then may recommend chemotherapy and radiation therapy. However, when the cancer spreads to both lungs, to the area around the lungs, or to other organs, treatment options like surgery, chemo, and radiation may not be enough. This means the cancer is considered advanced, and it’s time for something different.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.